Avania Names MedTech Industry Veteran, Todd M. Pope, New Chairman of the Board
전체 맥락을 이해하기 위해서는 본문 보기를 권장합니다.
"Todd's long history of leadership, coupled with his deep operating and commercial experience in the MedTech space makes him an ideal person for this role," said Sapna Hornyak, president and CEO of Avania. "I look forward to working closely with Todd to ensure Avania continues to make a positive impact for all stakeholders, including Avania's customers, our people, and the MedTech community. The senior management team along with the board of directors are excited about the future and look forward to bringing Avania to the next new phase with our new chairman."
이 뉴스는 기업·기관·단체가 뉴스와이어를 통해 배포한 보도자료입니다.
이 글자크기로 변경됩니다.
(예시) 가장 빠른 뉴스가 있고 다양한 정보, 쌍방향 소통이 숨쉬는 다음뉴스를 만나보세요. 다음뉴스는 국내외 주요이슈와 실시간 속보, 문화생활 및 다양한 분야의 뉴스를 입체적으로 전달하고 있습니다.
BILTHOVEN, Netherlands -- Businesswire -- Avania, a leading, global medical technology contract research organization (CRO), today announced its appointment of Todd M. Pope as the new chairman of the board of directors. Todd brings 30 years of technology, medical device, and leadership experience across large cap and startup MedTech and was named to TIME Magazine’s 2018 list of 50 Most Influential People in Healthcare. Having spent the last 20 years in CEO roles in both private and public companies, he also currently serves as the chairman of the board of directors of AdvaMed ACCEL, the division within AdvaMed dedicated to addressing the unique needs of small and startup medical technology manufacturers.
“I am very pleased to take on this role at such a dynamic time and support Avania on its growth journey,” said Pope. “After a rewarding career leading companies in the MedTech industry, I am motivated by the opportunity to work alongside the senior management team to execute on Avania’s transformational business strategy.”
Todd’s previous roles included global president of Johnson & Johnson Cordis, president and CEO of TransEnterix, as well as other senior executive positions within the MedTech space. Todd is currently director of the boards of Distalmotion and Humacyte, and a partner at Revival Healthcare Capital.
“Todd’s long history of leadership, coupled with his deep operating and commercial experience in the MedTech space makes him an ideal person for this role,” said Sapna Hornyak, president and CEO of Avania. “I look forward to working closely with Todd to ensure Avania continues to make a positive impact for all stakeholders, including Avania’s customers, our people, and the MedTech community. The senior management team along with the board of directors are excited about the future and look forward to bringing Avania to the next new phase with our new chairman.”
“We are very excited to be working with Todd,” added Edouard Pillot, managing partner, and Enrico Grasso, partner of Astorg Mid-Cap, which has majority interest in Avania. “He brings a wealth of MedTech industry experience and relationships that will provide invaluable connections with customers as well as insights into their evolving needs, and how Avania can best serve them. Todd’s leadership experience, with small and large businesses, will also support Avania as it grows and scales.”
About Avania
Avania is a leading, global full-service contract research organization focused on the management of clinical studies for medical devices, IVDs, biologics, and device-drug combination products internationally. Avania supports products from the first-in-human phase through the post-market phase with the same customized approach. When you need to advance your medical technology, it takes Avania. Avania’s vision is to be your trusted global partner in the evolution of your medical technology from innovation to commercialization to improving patient health and well-being.
View source version on businesswire.com: https://www.businesswire.com/news/home/20230316005199/en/
이 뉴스는 기업·기관·단체가 뉴스와이어를 통해 배포한 보도자료입니다.
출처:Avania
보도자료 통신사 뉴스와이어(www.newswire.co.kr) 배포
Copyright © 뉴스와이어. 무단전재 및 재배포 금지.
- 서울대 공대 전기정보공학부 권성훈 교수팀, 기존 백신 반복 접종만으로 변종 코로나 바이러스
- 오디에스-넥스테라, 다이렉트 투명교정장치 ‘AlignMiracle’ 사업화 MOU 및 임상계약 체결 - 뉴스와
- 생화학분자생물학회 국제학술대회, 5월 28일~31일 부산 벡스코서 개최 - 뉴스와이어
- 가야금 명인 오경희, 6월 13일 선릉아트홀서 ‘서공철류 가야금산조’ 전 바탕 선보여 - 뉴스와이
- 언제 어디서나 편하게 스케줄 확인, 다이얼독 비즈 모바일 앱 리뉴얼 - 뉴스와이어
- KB손해보험, 보장 분석 서비스 ‘보험 MBTI’ 출시 - 뉴스와이어
- 삼양사, 일본 식품전문전시회 ‘IFIA 2024’ 참가해 판로 확대 나서 - 뉴스와이어
- LG화학, KCC와 친환경 도료 개발 맞손 - 뉴스와이어
- 아트라스콥코, 컴프레서 업계 최초로 ‘페이백 프로그램’ 출시 - 뉴스와이어
- 삼성바이오로직스, 2024 바이오 인터내셔널 컨벤션 참가 ‘고객 맞춤’ 전략으로 글로벌 수주 확